<DOC>
	<DOCNO>NCT02080949</DOCNO>
	<brief_summary>Brain metastasis occur 20-40 % patient metastatic cancer . The standard treatment base whole brain radiation therapy local treatment metastasis neurosurgery radiosurgery . However , many case receive standard local treatment , local relapse occur almost 50 % case treat whole brain irradiation . There retrospective study increase radiation dose site metastasis hypofractionated stereotactic radiotherapy ( HSRT ) favorable result , controlled study regard safety radiation dose situation . This study phase I study evaluate maximum tolerance dose ( MTD ) HSRT way increase dose radiation WBRT patient 1-3 brain metastasis eligible surgery RS .</brief_summary>
	<brief_title>Phase I Dose Escalation Patients With 1-3 Unresectable Brain Metastases</brief_title>
	<detailed_description>RADIOTHERAPY WBRT Patient supine position Immobilization head thermoplastic mask Simulation compute tomography ( CT ) contrast . Design : Clinical target volume ( CTV ) : brain meninges foramen magnum Planned treatment volume ( PTV ) : 5 mm CTV direction - Planning : - Technique : Two latero-lateral field , permission use field inside field , know `` field-in-field '' . - Isodose prescription : 95 % dose cover 95 % PTV - Maximum dose allow PTV : 15 % high prescribe dose - Dose / fractionation : 30 Gy 10 fraction 3 Gy day , five time week - Treatment Equipment : Linear accelerator 6-MeV photon ( Varian Clinac 600 CD , Varian Medical Systems , Palo Alto , CA , USA ) HSRT Planning HSRT - Held seventh day post-WBRT ( next business day date coincides weekend holiday ) : - Patient supine position - Preparation individualize mask `` Mask Patient One set 41,100 ( BrainLAB AG , Heimstetten , Germany ) - Brain MRI contrast volumetric reconstruction 1 mm without mask without fiducial marker - Brain CT contrast , 1-mm slice track stereotactic fixation . - Fusion MRI CT planning system iPlan version 4.1 ( BrainLAB AG , Heimstetten , Germany ) - Delineation Gross tumor volume ( GTV ) : metastasis ( e ) brain display MRI signal T1 contrast Clinical target volume ( CTV ) = GTV Planning target volume ( PTV ) = CTV 3 mm margin direction - Physical Planning - Technique : multiple dynamic arc , multiple static conformal field , multiple static modulate field , multiple static arc - isodose prescription : high isodose meet follow criterion : Coverage least 95 % PTV prescription dose ( V100 ≥ 95 % ) 95 % Of prescription dose cover least 99 % PTV ( V95 ≥ 99 % ) . - Maximum dose allow outside PTV : 20 % prescription dose , respect tolerance organ describe . - Scores compliance RTOG - Dose escalation scheme Study model It 'll recruit 3 patient initial scheme 4 fraction 5 Gy brain metastasis HSRT patient unacceptable toxicity , 3 patient subsequent scheme recruit . If 2 patient unacceptable toxicity , study end 'll consider study initiate toxic regimen . If 1 patient unacceptable toxicity , 'll recruit 3 patient scheme 1 patient unacceptable toxicity , scheme consider toxic study close . If patient develops unacceptable toxicity , study follow next cohort 3 patient next dose level . The criterion recruitment perform till scheme reach MTD scheme 4 fraction 9 Gy . - The number fraction HSRT keep 4 fraction cohort . - The initial dose 5 Gy per day . - Increasing dose one cohort another 1 Gy per day HSRT . For example : If scheme 4 fraction 5 Gy unacceptable toxicity , study continue recruit patient scheme 4 fraction 6 Gy , subsequently . - The study recruit patient fractionation scheme four fraction 9 Gy accord BEDGy3 similar maximum dose RS study brain metastasis 24 Gy one fraction . - At discretion responsible investigator safety study , number patient may increase cohort study . - Restrictions radiation dose critical organ - optic chiasm : BEDGy3 : 90 Gy - optic nerve : BEDGy3 : 90 Gy - optic tract : BEDGy3 : 90 Gy - brainstem : BEDGy3 : 110 Gy - retina : BEDGy3 : 72 Gy - lens : BEDGy3 : 16.7 Gy - Simulation HSRT - Ten day post-WBRT ( next business day , date coincides weekend holiday ) - Tests collision safety quality control test ensure alignment isocenters radiation , mechanical coincidence laser ( Winston-Lutz test ) . - Treatment HSRT - Eleventh day post-WBRT ( next business day , date coincides weekend holiday ) - Treatment equipment - linear accelerator 6-MeV photon ( Varian Clinac linear accelerator 600 CD , Varian Medical Systems , Palo Alto , CA , USA ) - Micromultileaf m3 System ( BrainLAB AG , Heimstetten , Germany ) .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>Patients 13 brain metastasis histological diagnosis malignancy ineligible surgery RS Age ≥18 year Karnofsky Performance Status ( KPS ) ≥ 70 % `` Status '' neurological function : zero 3 Anticipated survival &gt; 3 month Informed consent research sign Prior brain irradiation reason Indian race Primary tumor lymphoma , leukemia , germ cell , small cell carcinoma central nervous system Leptomeningeal dissemination single multiple metastasis surgical ( patient KPS ≥ 70 , metastatic site area eloquent herniation cause mass effect hydrocephalus ) RS indication ( patient KPS ≥ 70 metastatic lesion &lt; 4 cm diameter distance chiasm , tract optic nerve , brain stem &gt; 5 mm ) Inability MRI Patients undergone prior treatment specific brain metastasis ( eg surgery , RS , chemotherapy ) , exclude corticosteroid People mental incapacity People relationship dependence prisoner , soldier , student , staff , etc..</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>brain metastasis , hypofractionated stereotactic radiotherapy</keyword>
</DOC>